Even with decreases in cardiovascular disease, kidney failure and possible decreases in cancer, employers should be aware that GLP-1 drugs will not lower overall health care costs
Robert Kushner: I haven't seen that paper, but what I can say which I thought you were getting to is that when we look at the categorical weight loss in all these trials, so some people lose 5%, 10%, 20%, 25% over the course of the trial, if you then stop the medication, the individuals who lost the greatest amount of body weight actually are the ones that regain it the quickest
I am so thankful for the benefits
b , i , l , o , Venn-diagram with differentially regulated proteins (DRPs) over vehicle in pancreas ( b ), eWAT ( i ), liver ( l ) and skeletal muscle ( o )